{
    "clinical_study": {
        "@rank": "18448", 
        "arm_group": [
            {
                "arm_group_label": "PN selenium and formula sodium selenate", 
                "arm_group_type": "Experimental", 
                "description": "Parenteral nutrition (PN) with selenium and sodium selenate supplementation of infant formula"
            }, 
            {
                "arm_group_label": "PN selenium and formula sodium selenite", 
                "arm_group_type": "Experimental", 
                "description": "Parenteral nutrition (PN) with selenium and sodium selenite supplementation of infant formula"
            }, 
            {
                "arm_group_label": "PN without selenium and formula sodium selenate", 
                "arm_group_type": "Experimental", 
                "description": "Parenteral nutrition (PN) without selenium and sodium selenate supplementation of infant formula"
            }, 
            {
                "arm_group_label": "PN without selenium and formula sodium selenite", 
                "arm_group_type": "Experimental", 
                "description": "Parenteral nutrition (PN) without selenium and sodium selenite supplementation of infant formula"
            }
        ], 
        "brief_summary": {
            "textblock": "The objectives of the study were to assess the serum selenium, zinc, and copper status and\n      plasma and white blood cell antioxidant enzyme activities of low birth weight infants\n      receiving selenium supplemented and non-selenium supplemented parenteral nutrition from\n      initiation of parenteral nutrition until discontinuation of preterm formula or hospital\n      discharge."
        }, 
        "brief_title": "Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants", 
        "completion_date": {
            "#text": "June 1993", 
            "@type": "Actual"
        }, 
        "condition": "Preterm Infants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Weight less than 1500 g at birth\n\n          -  Not capable of receiving enteral feedings prior to 7 days postnatally\n\n        Exclusion Criteria:\n\n          -  Metabolic abnormalities such as inborn errors of metabolism\n\n          -  Current viral infections\n\n          -  Enterocolitis confirmed by diagnosis\n\n          -  Presence of congenital anomalies, severe cardiac disease, liver disease, severe renal\n             and neurological diseases, cholestasis, hemolytic disease and severe gastrointestinal\n             disease\n\n          -  Evidence of chronic white blood cell disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "47", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066610", 
            "org_study_id": "AD61"
        }, 
        "intervention": [
            {
                "arm_group_label": "PN selenium and formula sodium selenate", 
                "description": "Parenteral nutrition with selenium and sodium selenate supplementation of infant formula", 
                "intervention_name": "selenium and sodium selenate supplementation", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "PN selenium and formula sodium selenite", 
                "description": "Parenteral nutrition with selenium and sodium selenite supplementation of infant formula", 
                "intervention_name": "selenium and sodium selenite supplementation", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "PN without selenium and formula sodium selenate", 
                "description": "Parenteral nutrition without selenium and sodium selenate supplementation of infant formula", 
                "intervention_name": "Without selenium and sodium selenate supplementation", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "PN without selenium and formula sodium selenite", 
                "description": "Parenteral nutrition without selenium and sodium selenite supplementation of infant formula", 
                "intervention_name": "Without selenium and sodium selenite supplementation", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Selenium", 
                "Sodium selenate", 
                "Trace Elements", 
                "Micronutrients"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97227"
                }, 
                "name": "Legacy Emanuel Children's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Parenteral and Enteral Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Low Birth Weight Infants", 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Marlene Borschel, Ph.D", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 1993", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
            "measure": "Serum Selenium", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline to Discharge (~50-60 days)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066610"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Weight at study day 1, at first enteral feed, at full enteral feeding, and at study exit", 
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "Change from study day 1 to study exit (~50-60 days)"
            }, 
            {
                "description": "Length at study day 1, at first enteral feed, at full enteral feeding, and at study exit", 
                "measure": "Length", 
                "safety_issue": "No", 
                "time_frame": "Change from study day 1 to study exit (~50-60 days)"
            }, 
            {
                "description": "Head circumference at study day 1, at first enteral feed, at full enteral feeding, and at study exit", 
                "measure": "Head Circumference", 
                "safety_issue": "No", 
                "time_frame": "Change from study day 1 to study exit (~50-60 days)"
            }, 
            {
                "description": "Daily recording of volume and calories from parenteral solutions and study formula consumed", 
                "measure": "Intake", 
                "safety_issue": "No", 
                "time_frame": "Change from study day 1 to study exit (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "Serum Copper", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "Serum Zinc", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "WBC Super oxide dismutase (SOD) activity", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "Glutathione peroxidase (GSHpx) activity", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "Plasma GSHpx activity", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }, 
            {
                "description": "4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge", 
                "measure": "Plasma Amino Acid Concentrations", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to Discharge (~50-60 days)"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 1991", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}